Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig W Lindsley

Showing results (1-10 of 741) with videos related to

Pageof 75
Sort By:
ACS Chemical Neuroscience|March 21, 2019
Predictions and Statistics for the Best-Selling Drugs Globally and in the United States in 2018 and a Look Forward to 2024 ProjectionsCraig W Lindsley
ACS Chemical Neuroscience|March 21, 2019
Call for Papers: Strategies and Tactics in CNS Drug SynthesisCraig W Lindsley
ACS Chemical Neuroscience|August 18, 2016
Lost in Translation: The Death of Basic ScienceCraig W Lindsley
ACS Chemical Neuroscience|April 17, 2014
2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeuticsCraig W Lindsley
ACS Chemical Neuroscience|December 10, 2016
ACS Editors' Choice: Providing Recognition to Authors and Open Access to the CommunityCraig W Lindsley
ACS Chemical Neuroscience|August 17, 2012
The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeuticsCraig W Lindsley
ACS Chemical Neuroscience|July 11, 2012
The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossingCraig W Lindsley
ACS Chemical Neuroscience|July 11, 2012
(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD)Craig W Lindsley
ACS Chemical Neuroscience|July 11, 2012
The top prescription drugs of 2010 in the United States: antipsychotics show strong growthCraig W Lindsley
ACS Chemical Neuroscience|March 21, 2013
New hope for multiple sclerosis patientsCraig W Lindsley
Pageof 75

Showing results (1-10 of 741) with videos related to

Sort By:
Pageof 75
ACS Chemical Neuroscience|March 21, 2019
Predictions and Statistics for the Best-Selling Drugs Globally and in the United States in 2018 and a Look Forward to 2024 ProjectionsCraig W Lindsley
ACS Chemical Neuroscience|March 21, 2019
Call for Papers: Strategies and Tactics in CNS Drug SynthesisCraig W Lindsley
ACS Chemical Neuroscience|August 18, 2016
Lost in Translation: The Death of Basic ScienceCraig W Lindsley
ACS Chemical Neuroscience|April 17, 2014
2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeuticsCraig W Lindsley
ACS Chemical Neuroscience|December 10, 2016
ACS Editors' Choice: Providing Recognition to Authors and Open Access to the CommunityCraig W Lindsley
ACS Chemical Neuroscience|August 17, 2012
The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeuticsCraig W Lindsley
ACS Chemical Neuroscience|July 11, 2012
The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossingCraig W Lindsley
ACS Chemical Neuroscience|July 11, 2012
(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD)Craig W Lindsley
ACS Chemical Neuroscience|July 11, 2012
The top prescription drugs of 2010 in the United States: antipsychotics show strong growthCraig W Lindsley
ACS Chemical Neuroscience|March 21, 2013
New hope for multiple sclerosis patientsCraig W Lindsley
Pageof 75